Full Text View
Tabular View
No Study Results Posted
Related Studies
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
This study has been completed.
Study NCT00075569   Information provided by National Cancer Institute (NCI)
First Received: January 9, 2004   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Cancer
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Cervical Intraepithelial Neoplasia
Precancerous Conditions
More general conditions related to this trial
Carcinoma
Carcinoma in Situ
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
HspE7
Sponsors listed in this trial
Albert Einstein College of Medicine of Yeshiva University
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services